Cargando…
Durable Control and Overall Survival Benefit with Focal Reirradiation in Cervical Cancer
Local recurrence following definitive chemoradiation in cervical cancer ranges from 5-18%. Currently, there are limited options available for patients recurring in para-aortic or iliac lymph nodes. We present two cases of reirradiation for non-central recurrences with intensity-modulated radiotherap...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725673/ https://www.ncbi.nlm.nih.gov/pubmed/26824003 http://dx.doi.org/10.7759/cureus.399 |
_version_ | 1782411666287230976 |
---|---|
author | Amini, Arya Sumner, Whitney Fisher, Christine M |
author_facet | Amini, Arya Sumner, Whitney Fisher, Christine M |
author_sort | Amini, Arya |
collection | PubMed |
description | Local recurrence following definitive chemoradiation in cervical cancer ranges from 5-18%. Currently, there are limited options available for patients recurring in para-aortic or iliac lymph nodes. We present two cases of reirradiation for non-central recurrences with intensity-modulated radiotherapy (IMRT). Both patients achieved a complete response with manageable short-term toxicities and no late adverse effects with a follow-up of over one year and three years after reirradiation. While further follow-up is needed, IMRT is a feasible and safe option in cervical cancer patients with recurrent in-field failures involving the lymph nodes. |
format | Online Article Text |
id | pubmed-4725673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-47256732016-01-28 Durable Control and Overall Survival Benefit with Focal Reirradiation in Cervical Cancer Amini, Arya Sumner, Whitney Fisher, Christine M Cureus Radiation Oncology Local recurrence following definitive chemoradiation in cervical cancer ranges from 5-18%. Currently, there are limited options available for patients recurring in para-aortic or iliac lymph nodes. We present two cases of reirradiation for non-central recurrences with intensity-modulated radiotherapy (IMRT). Both patients achieved a complete response with manageable short-term toxicities and no late adverse effects with a follow-up of over one year and three years after reirradiation. While further follow-up is needed, IMRT is a feasible and safe option in cervical cancer patients with recurrent in-field failures involving the lymph nodes. Cureus 2015-12-11 /pmc/articles/PMC4725673/ /pubmed/26824003 http://dx.doi.org/10.7759/cureus.399 Text en Copyright © 2015, Amini et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Radiation Oncology Amini, Arya Sumner, Whitney Fisher, Christine M Durable Control and Overall Survival Benefit with Focal Reirradiation in Cervical Cancer |
title | Durable Control and Overall Survival Benefit with Focal Reirradiation in Cervical Cancer |
title_full | Durable Control and Overall Survival Benefit with Focal Reirradiation in Cervical Cancer |
title_fullStr | Durable Control and Overall Survival Benefit with Focal Reirradiation in Cervical Cancer |
title_full_unstemmed | Durable Control and Overall Survival Benefit with Focal Reirradiation in Cervical Cancer |
title_short | Durable Control and Overall Survival Benefit with Focal Reirradiation in Cervical Cancer |
title_sort | durable control and overall survival benefit with focal reirradiation in cervical cancer |
topic | Radiation Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725673/ https://www.ncbi.nlm.nih.gov/pubmed/26824003 http://dx.doi.org/10.7759/cureus.399 |
work_keys_str_mv | AT aminiarya durablecontrolandoverallsurvivalbenefitwithfocalreirradiationincervicalcancer AT sumnerwhitney durablecontrolandoverallsurvivalbenefitwithfocalreirradiationincervicalcancer AT fisherchristinem durablecontrolandoverallsurvivalbenefitwithfocalreirradiationincervicalcancer |